Global Super Nuclease Market Growth 2025-2031

The global Super Nuclease market size is predicted to grow from US$ 390 million in 2025 to US$ 647 million in 2031; it is expected to grow at a CAGR of 8.8% from 2025 to 2031.

Super Nuclease, a genetically engineered enzyme from Serratia Marcescen. It can degrade all forms of DNA and RNA, including single-stranded, double-stranded, linear, circular, native and denatured nucleic acids, digesting them into 5-monophosphate oligonucleotides of 3-8 bases in length, and has no base recognition specificity.

United States market for Super Nuclease is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Super Nuclease is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Super Nuclease is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Super Nuclease players cover Thermo Fisher Scientific Inc., RayBiotech, Inc., TransGen Biotech, AbMole BioScience, Yisheng Biotechnology (Shanghai) Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Super Nuclease Industry Forecast” looks at past sales and reviews total world Super Nuclease sales in 2024, providing a comprehensive analysis by region and market sector of projected Super Nuclease sales for 2025 through 2031. With Super Nuclease sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Super Nuclease industry.

This Insight Report provides a comprehensive analysis of the global Super Nuclease landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Super Nuclease portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Super Nuclease market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Super Nuclease and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Super Nuclease.

This report presents a comprehensive overview, market shares, and growth opportunities of Super Nuclease market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
5kU
25kU
50kU
100kU
＞100kU

Segmentation by Application:
Biological Laboratory
University Research Room
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific Inc.
RayBiotech, Inc.
TransGen Biotech
AbMole BioScience
Yisheng Biotechnology (Shanghai) Co., Ltd.
GenScript
Shanghai Biyuntian Biotechnology Co., Ltd.
KACTUS
Shanghai Zhudian Biotechnology Co., Ltd.
ACROBiosystems Group

Key Questions Addressed in this Report

What is the 10-year outlook for the global Super Nuclease market?

What factors are driving Super Nuclease market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Super Nuclease market opportunities vary by end market size?

How does Super Nuclease break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.